NCT00594100View on ClinicalTrials.gov

GORE Embolic Protection With Reverse Flow

PHASE3CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Carotid Artery Stenosis
Interventions
DEVICE

GORE Flow Reversal System (GFRS)

Carotid artery angioplasty and stenting with embolic protection

Trial Locations (2)

14209

Millard Fillmore Gates/Univ. of Buffalo, Buffalo

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT00594100 - GORE Embolic Protection With Reverse Flow | Biotech Hunter | Biotech Hunter